Serpin Pharma (Biotechnology, Health Care) — Funding, Investors & Signals 2026

Serpin Pharma

Enhancing cell resilience: A revolutionary approach for inflammatory diseases

Founded 2011

Manassas, United States 8 employees Grant Total: $400.00K Biotechnology, Health Care +1

Serpin Pharma is a biotechnology and health care startup based in the United States, founded in 2011. The company's slogan "Enhancing cell resilience: A revolutionary approach for inflammatory diseases" reflects its core focus on developing targeted therapeutics to enhance the body’s natural immune response. By reducing inflammation and restoring immune balance, Serpin Pharma aims to address critical unmet needs in the treatment of inflammatory diseases. The startup received a significant boost with a $400.00K grant investment on 21 June 2017, with the Virginia Catalyst as the investor. This investment not only underscores the potential of Serpin Pharma's innovative approach but also demonstrates the confidence of external stakeholders in the company's vision and capabilities. This injection of capital is an opportunity for the company to propel its research and development efforts, moving closer to realizing its mission of developing impactful therapies for inflammatory diseases. In conclusion, Serpin Pharma stands at the intersection of biotechnology and healthcare, offering a promising solution to address the challenges of inflammatory diseases. With strategic investments and a focused approach, the company is poised to make meaningful contributions to the field of immune response modulation and inflammation management.

Funding Stage	Amount	Investors	Lead Investors	Date
Grant	••••••	1	•••• ••••	21 Jun 2017

Funding Stage

Amount

Investors

Lead Investors

Date

Grant

••••••

•••• ••••

21 Jun 2017

FAQ About Serpin Pharma

Enhancing cell resilience: A revolutionary approach for inflammatory diseases

Serpin Pharma was founded in 2011.

Serpin Pharma is headquartered in Manassas, United States.

Serpin Pharma operates in the following industries: Biotechnology, Health Care, Health and Wellness.

Serpin Pharma has approximately 8 employees.

Serpin Pharma has completed 1 funding round, raising a total of $400.00K. The latest funding stage is Grant.

Top alternatives and competitors to Serpin Pharma include 13therapeutics, Nuvig Therapeutics Inc., Q32 Bio Inc., Delinia, AltruBio Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Serpin Pharma and 13therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Serpin Pharma

General Information

Track Serpin Pharma

Discover More

About Serpin Pharma

Funding Rounds & Investors (1)

Serpin Pharma Alternatives & Competitors

FAQ About Serpin Pharma

Don't just browse. Track.